Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery

By Kowalczyk Aleksandra   Wierzbicki Andrzej   Gil Margaret   Bambach Barbara   Kaneko Yutaro   Rokita Hanna   Repasky Elizabeth   Fenstermaker Robert   Brecher Martin   Ciesielski Michael   Kozbor Danuta  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1443-1458

Springer Publishing Company

Access to resources Recommend Favorite

Disialoganglioside Directed Immunotherapy of Neuroblastoma

By Modak Shakeel   Cheung Nai-Kong  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 67-77

Informa Healthcare

Access to resources Recommend Favorite

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy

By Ruiz-Cabello F.   Cabrera T.   Lopez-Nevot M-A.   Garrido F.  

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 403-405

Academic Press

Access to resources Recommend Favorite

Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-09 ,pp. : 239-254

Bentham Science Publishers

Access to resources Recommend Favorite

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

By Prell Rodney   Gearin Lisa   Simmons Andrew   VanRoey Melinda   Jooss Karin  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1285-1293

Springer Publishing Company

Access to resources Recommend Favorite